High Prevalence of Sarcopenia in HIV-Infected Individuals

Table 1

Clinical and epidemiological characteristics of the study population at time of the first DXA scan.

	N=860
Age, years (median [IQR])	52 (47; 57)
Age ≥50 years (%)	59
Gender (male) (%)	76
Time since diagnosis of HIV infection, years (median [IQR])	8 (3; 15)
Cumulative exposure to antiretrovirals, years (median [IQR])	8 (3; 14)
CD4 cell count/μL (median [IQR]) (baseline)	552 (377; 728)
HIV-RNA ≤50 copies/mL (%)	94
Osteopenia/osteoporosis (%)	51 / 18
Body mass index (median [IQR])	23 (21; 25)
Total cholesterol (mmol/ml) (median [IQR])	4.7 (4; 5.7)

DXA (dual-energy X-ray absorptiometry).